Ascendia Pharmaceuticals reported raising $2.5 Million in an initial SEC Form D filing, from an offering of $2.5 Million
Amount Raised
$2.5 Million
$2.5 Million sold, per
SEC Form D (first sale May 22, 2025)
New BrunswickManufacturingBiotechnologyHealthcarePharmaceuticalWho to call at Ascendia Pharmaceuticals, and when
A new round usually means Ascendia Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ascendia Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ascendia Pharmaceuticals, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★ 4.8/5 on G2
Location
661 US HIGHWAY ONE
New Brunswick, New Jersey, United States
About
Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ascendia Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ascendia Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
